HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 40341Generated: October 29, 2026
2-(Dicyclohexylphosphino)biphenyl → 6-((R)-1-(5-(thiazol-4-yl)isoxazolo[5,4-b]pyridin-3-yl)ethyl)quinoline
https://huagongshe.com/reaction/40341
Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | 2-(Dicyclohexylphosphino)biphenyl | HCID 2734216 | — |
| Reactant | 4-(Tri-n-butylstannyl)thiazole | HCID 2763258 | — |
| Reactant | 6-(1-(5-Bromoisoxazolo[5,4-b]pyridin-3-yl)ethyl)quinoline | HCID 57691330 | — |
| Solvent | Dimethylformamide | HCID 6228 | — |
| Product | 6-((R)-1-(5-(thiazol-4-yl)isoxazolo[5,4-b]pyridin-3-yl)ethyl)quinoline | HCID 57691192 | — |
Reaction Steps
To a pressure vessel was added 2-(dicyclohexylphosphino)biphenyl (12 mg, 0.42 mmol), 6-(1-(5-bromoisoxazolo[5,4-b]pyridin-3-yl)ethyl)quinoline (0.10 g, 0.28 mmol), 4-(tributylstannyl)thiazole (0.16 g, 0.42 mmol) in anhydrous DMF (3 mL). The vial was flushed with argon, sealed and stirred at 90° C. for two hours. The mixture was concentrated and purified by MPLC (eluted with a gradient of 0 to 10% methanol in dichloromethane) to yield the racemic product as an off-white solid. The desired enantiomer (>99% ee) was obtained via SFC. MS m/z=359.0 [M+1]+ Calc'd for C20H14N4OS: 358.4
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08524900B2 |
|---|
| Source dataset | uspto-grants-2013_09 |
|---|
| ORD ID | ord-910158b84daa42a0975dafd4e16f0c10 |
|---|
| Source note | uspto-grants-2013_09 |
|---|